Listed

Sunshine Biopharma Inc.: Form 10-Q for the period ended Sep 30, 2015

Filed with the SEC on Nov 4, 2015 and accepted by EDGAR at Nov 4, 2015, 14:41 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2015-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2015-07-01 to 2015-09-30$0us-gaap:SalesRevenueGoodsNet
Revenue9 months2015-01-01 to 2015-09-30$1.7kus-gaap:SalesRevenueGoodsNet
Research and development3 months2015-07-01 to 2015-09-30$8.7kus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2015-01-01 to 2015-09-30$8.7kus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2015-07-01 to 2015-09-30−$113.1kus-gaap:OperatingIncomeLoss
Operating income9 months2015-01-01 to 2015-09-30−$606.0kus-gaap:OperatingIncomeLoss
Interest expense3 months2015-07-01 to 2015-09-30$9.8kus-gaap:InterestExpense
Interest expense9 months2015-01-01 to 2015-09-30$49.2kus-gaap:InterestExpense
Net income3 months2015-07-01 to 2015-09-30−$202.8kus-gaap:NetIncomeLoss
Net income9 months2015-01-01 to 2015-09-30−$1.0mus-gaap:NetIncomeLoss
Basic EPS3 months2015-07-01 to 2015-09-30$0.00us-gaap:EarningsPerShareBasic
Basic EPS9 months2015-01-01 to 2015-09-30−$0.01us-gaap:EarningsPerShareBasic
Operating cash flow9 months2015-01-01 to 2015-09-30−$523.7kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2015-09-30$125.2kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2015-09-30$136.6kus-gaap:AssetsCurrent
Total assetsAt period end2015-09-30$136.6kus-gaap:Assets
Current liabilitiesAt period end2015-09-30$469.6kus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2015-09-30$469.6kus-gaap:Liabilities
Shareholders' equityAt period end2015-09-30−$332.9kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001354488-15-004810. Last ingested by Listed: Nov 14, 2026, 19:46 ET. Listed shows no prices and gives no investment advice.